Expression of genes regulating malonyl-CoA in human skeletal muscle

Journal of Cellular Biochemistry

Volumn 99, Issue 3, 2006, Pages 860-867

  Pender, Celia ^a   Trentadue, Anna R ^a   Pories, Walter J ^b   Dohm, G Lynis ^b   Houmard, Joseph A ^c   Youngren, Jack F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b EAST CAROLINA UNIVERSITY   (United States)

^c EAST CAROLINA UNIVERSITY   (United States)

Author keywords

Acetyl CoA carboxylase; Fatty acid synthase; Lipogenesis; Obesity; Pyruvate carboxylase; Sterol regulatory element binding protein 1

Indexed keywords

ACETYL COENZYME A; ACETYL COENZYME A CARBOXYLASE; ACETYL COENZYME A CARBOXYLASE 2; CARBOXYLYASE; CARNITINE PALMITOYLTRANSFERASE; FATTY ACID SYNTHASE; LIPID; LONG CHAIN FATTY ACID; MALONYL COENZYME A; MALONYL COENZYME A DECARBOXYLASE; MESSENGER RNA; UNCLASSIFIED DRUG;

ADULT; ALLOSTERISM; ARTICLE; CELL METABOLISM; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN TISSUE; INSULIN RESISTANCE; LEAN BODY WEIGHT; LIPID METABOLISM; LIPID OXIDATION; LIPID STORAGE; LIPOGENESIS; MALE; MITOCHONDRION; MORBID OBESITY; MUSCLE BIOPSY; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RNA TRANSCRIPTION; SKELETAL MUSCLE; TRANSCRIPTION REGULATION;

ACETYL-COA CARBOXYLASE; ADULT; ANIMALS; BIOPSY; CARBOXY-LYASES; CARNITINE O-PALMITOYLTRANSFERASE; FATTY ACID SYNTHETASE COMPLEX; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; ISOENZYMES; MALONYL COENZYME A; MUSCLE, SKELETAL; OBESITY; PYRUVATE CARBOXYLASE; STEROL REGULATORY ELEMENT BINDING PROTEIN 1;

ANIMALIA;

EID: 33749496348     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.20944     Document Type: Article

References (42)

1. Aas V, Kase ET, Solberg R, Jensen J, Rustan AC. 2004. Chronic hyperglycaemia promotes lipogenesis and triacylglycerol accumulation in human skeletal muscle cells. Diabetologia 47:1452-1461.
2. Abu-Elheiga L, Brinkley WR, Zhong L, Chirala SS, Woldegiorgis G, Wakil SJ. 2000. The subcellular localization of acetyl-CoA carboxylase 2. Proc Natl Acad Sci USA 97:1444-1449.
3. Bianchi A, Evans JL, Iverson AJ, Nordlund AC, Watts TD, Witters LA. 1990. Identification of an isozymic form of acetyl-CoA carboxylase. J Biol Chem 265:1502-1509.
4. Boden G. 2002. Interaction between free fatty acids and glucose metabolism. Curr Opin Clin Nutr Metab Care 5:545-549.
5. Brownsey RW, Zhande R, Boone AN. 1997. Isoforms of acetyl-CoA carboxylase: Structures, regulatory properties and metabolic functions. Biochem Soc Trans 25:1232-1238.
6. DeFronzo RA. 1988. Lilly lecture 1987. The triumvirate: Beta-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes 37:667-687.
7. Dulloo AG, Gubler M, Montani JP, Seydoux J, Solinas G. 2004. Substrate cycling between de novo lipogenesis and lipid oxidation: A thermogenic mechanism against skeletal muscle lipotoxicity and glucolipotoxicity. Int J Obes Relat Metab Disord 28(Suppl 4):S29-S37.
8. Fabris R, Mingrone G, Milan G, Manco M, Granzotto M, Dalla PA, Scarda A, Serra R, Greco AV, Federspil G, Vettor R. 2004. Further lowering of muscle lipid oxidative capacity in obese subjects after biliopancreatic diversion. J Clin Endocrinol Metab 89:1753-1759.
9. Farfari S, Schulz V, Corkey B, Prentki M. 2000. Glucose-regulated anaplerosis and cataplerosis in pancreatic beta-cells: Possible implication of a pyruvate/citrate shuttle in insulin secretion. Diabetes 49:718-726.
10. Foretz M, Guichard C, Ferre P, Foufelle F. 1999a. Sterol regulatory element binding protein-1c is a major mediator of insulin action on the hepatic expression of glucokinase and lipogenesis-related genes. Proc Natl Acad Sci USA 96:12737-12742.
11. Foretz M, Pacot C, Dugail I, Lemarchand P, Guichard C, Le L, Berthelier-Lubrano C, Spiegelman B, Kim JB, Ferre P, Foufelle F. 1999b. ADD1/SREBP-1c is required in the activation of hepatic lipogenic gene expression by glucose. Mol Cell Biol 19:3760-3768.
12. Gosmain Y, Lefai E, Ryser S, Roques M, Vidal H, 2004. Sterol regulatory element-binding protein-1 mediates the effect of insulin on hexokinase II gene expression in human muscle cells. Diabetes 53:321-329.
13. Gosmain Y, Dif N, Berbe V, Loizon E, Rieusset J, Vidal H, Lefai E. 2005. Regulation of SREBP-1 expression and transcriptional action on HKII and FAS genes during fasting and refeeding in rat tissues. J Lipid Res 46:697-705.
14. Guillet-Deniau I, Mieulet V, Le Lay S, Achouri Y, Carre D, Girard J, Foufelle F, Ferre P. 2002. Sterol regulatory element binding protein-1c expression and action in rat muscles: Insulin-like effects on the control of glycolytic and lipogenic enzymes and UCP3 gene expression. Diabetes 51:1722-1728.
15. Guillet-Deniau I, Pichard AL, Kone A, Esnous C, Nieruchalski M, Girard J, Prip-Buus C. 2004. Glucose induces de novo lipogenesis in rat muscle satellite cells through a sterol-regulatory-element-binding-protein-1c-dependent pathway. J Cell Sci 117:1937-1944.
16. Hegarty BD, Furler SM, Ye J, Cooney GJ, Kraegen EW. 2003. The role of intramuscular lipid in insulin resistance. Acta Physiol Scand 178:373-383.
17. Jitrapakdee S, Wallace JC. 1999. Structure, function and regulation of pyruvate carboxylase. Biochem J 340:1-16.
18. Jitrapakdee S, Gong Q, MacDonald MJ, Wallace JC. 1998. Regulation of rat pyruvate carboxylase gene expression by alternate promoters during development, in genetically obese rats and in insulin-secreting cells. Multiple transcripts with 5′-end heterogeneity modulate translation. J Biochem 273:34422-34428.
19. Jitrapakdee S, Slawik M, Medina-Gomez G, Campbell M, Wallace JC, Sethi JK, O'rahilly S, Vidal-Puig AJ. 2005. The peroxisome proliferator-activated receptor-gamma regulates murine pyruvate carboxylase gene expression in vivo and in vitro. J Biol Chem 280:27466-27476.
20. Kaput J, Rodriguez RL. 2004. Nutritional genomics: The next frontier in the postgenomic era. Physiol Genomics 16:166-177.
21. Kelley DE, Mandarino LJ. 2000. Fuel selection in human skeletal muscle in insulin resistance: A reexamination. Diabetes 49:677-683.
22. Kelley DE, Goodpaster B, Wing RR, Simoneau JA. 1999. Skeletal muscle fatty acid metabolism in association with insulin resistance, obesity, and weight loss. Am J Physiol 277:1130-1141.
23. Lafontan M. 2005. Fat cells: Afferent and efferent messages define new approaches to treat obesity. Annu Rev Pharmacol Toxicol 45:119-146.
24. Lam TK, Carpentier A, Lewis GF, van de WG, Fantus IG, Giacca A. 2003. Mechanisms of the free fatty acid-induced increase in hepatic glucose production. Am J Physiol Endocrinol Metab 284:E863-E873.
25. Lazar MA. 2005. How obesity causes diabetes: Not a tall tale. Science 307:373-375.
26. Lee GY, Kim NH, Zhao ZS, Cha BS, Kim YS. 2004. Peroxisomal-proliferator- activated receptor alpha activates transcription of the rat hepatic malonyl-CoA decarboxylase gene: A key regulation of malonyl-CoA lelvel. Biochem J 15:983-990.
27. Liu YQ, Jetton TL, Leahy JL. 2002. beta-Cell adaptation to insulin resistance. Increased pyruvate carboxylase and malate-pyruvate shuttle activity in islets of nondiabetic Zucker fatty rats. J Biol Chem 277:39163-39168.
28. MacDonald MJ. 1995. Influence of glucose on pyruvate carboxylase expression in pancreatic islets. Arch Biochem Biophys 319:128-132.
29. Martin-Requero A, Cipres G, Rodriguez A, Ayuso MS, Parrilla R. 1992. On the mechanism of stimulation of ureagenesis by gluconeogenic substrates: Role of pyruvate carboxylase. Am J Physiol 263:E493-E499.
30. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. 1985. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419.
31. McGarry JD. 2002. Banting lecture 2001: Dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes 51:7-18.
32. Mensink M, Blaak EE, Vidal H, De Bruin TW, Glatz JF, Saris WH. 2003. Lifestyle changes and lipid metabolism gene expression and protein content in skeletal muscle of subjects with impaired glucose tolerance. Diabetologia 46:1082-1089.
33. Munday MR. 2002. Regulation of mammalian acetyl-CoA carboxylase. Biochem Soc Trans 30:1059-1064.
34. Ruderman NB, Saha AK, Vawas D, Witters LA. 1999. Malonyl-CoA, fuel sensing, and insulin resistance. Am J Physiol 276:E1-E18.
35. Ruderman NB, Saha AK, Kraegen EW. 2003. Minireview: Malonyl CoA, AMP-activated protein kinase, and adiposity. Endocrinology 144:5166-5171.
36. Saha AK, Kurowski TG, Colca JR, Ruderman NB. 1994. Lipid abnormalities in tissues of the KKAy mouse: Effects of pioglitazone on malonyl-CoA and diacylglycerol. Am J Physiol 267:95-101.
37. Schmitz-Peiffer C, Craig DL, Biden TJ. 1999. Ceramide generation is sufficient to account for the inhibition of the insulin-stimulated PKB pathway in C2C12 skeletal muscle cells pretreated with palmitate. J Biol Chem 274:24202-24210.
38. Shimano H, Horton JD, Shimomura I, Hammer RE, Brown MS, Goldstein JL. 1997. Isoform 1c of sterol regulatory element binding protein is less active than isoform 1a in livers of transgenic mice and in cultured cells. J Clin Invest 99:846-854.
39. Shimomura I, Shimano H, Horton JD, Goldstein JL, Brown MS. 1997. Differential expression of exons 1a and 1c in mRNAs for sterol regulatory element binding protein-1 in human and mouse organs and cultured cells. J Clin Invest 99:838-845.
40. Simoneau JA, Veerkamp JH, Turcotte LP, Kelley DE. 1999. Markers of capacity to utilize fatty acids in human skeletal muscle: Relation to insulin resistance and obesity and effects of weight loss. FASEB J 13:2051-2060.
41. Virkamaki A, Korsheninnikova E, Seppala-Lindroos A, Vehkavaara S, Goto T, Halavaara J, Hakkinen AM, Yki-Jarvinen H. 2001. Intramyocellular lipid is associated with resistance to in vivo insulin actions on glucose uptake, antilipolysis, and early insulin signaling pathways in human skeletal muscle. Diabetes 50:2337-2343.
42. Witters LA, Widmer J, King AN, Fassihi K, Kuhajda F. 1994. Identification of human acetyl-CoA carboxylase isozymes in tissue and in breast cancer cells. Int J Biochem 26:589-594.